Literature DB >> 7922125

Indolocarbazole protein kinase C inhibitors from rebeccamycin.

S Fabre1, M Prudhomme, M Sancelme, M Rapp.   

Abstract

Structural modifications were carried out on rebeccamycin, an antitumour antibiotic, to obtain analogues. The inhibitory potencies of these analogues against protein kinase C are compared. The method described represents an alternative route to the staurosporine aglycone, a potent protein kinase C inhibitor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7922125     DOI: 10.1016/s0968-0896(00)82003-9

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Preparation of dibenzo[e,g]isoindol-1-ones via Scholl-type oxidative cyclization reactions.

Authors:  Amy A van Loon; Maeve K Holton; Catherine R Downey; Taryn M White; Carly E Rolph; Stephen R Bruening; Guanqun Li; Katherine M Delaney; Sarah J Pelkey; Erin T Pelkey
Journal:  J Org Chem       Date:  2014-08-25       Impact factor: 4.354

2.  Antikinetoplastid Activity of Indolocarbazoles from Streptomyces sanyensis.

Authors:  Luis Cartuche; Ines Sifaoui; Atteneri López-Arencibia; Carlos J Bethencourt-Estrella; Desirée San Nicolás-Hernández; Jacob Lorenzo-Morales; José E Piñero; Ana R Díaz-Marrero; José J Fernández
Journal:  Biomolecules       Date:  2020-04-24

3.  Evaluation of Indolocarbazoles from Streptomyces sanyensis as a Novel Source of Therapeutic Agents against the Brain-Eating Amoeba Naegleria fowleri.

Authors:  Aitor Rizo-Liendo; Ines Sifaoui; Luis Cartuche; Iñigo Arberas-Jiménez; María Reyes-Batlle; José J Fernández; José E Piñero; Ana R Díaz-Marrero; Jacob Lorenzo-Morales
Journal:  Microorganisms       Date:  2020-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.